Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D
about
Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes.Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.Assembly of avian reticuloendotheliosis virus: association of the core precursor polypeptide with the intracellular ribonucleoprotein complex.Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses.Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus coreReplication-defective Friend murine leukemia virus particles containing uncleaved gag polyproteins and decreased levels of envelope glycoproteinEndodeoxyribonuclease activity associated with Rauscher murine leukemia virusDeterminants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA.Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene.Characterization of the proteins of intracisternal type A and extracellular oncornavirus-like particles produced by MOPC-460 myeloma cells.Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products.Inhibition of maturation of Rauscher leukemia virus by amino acid analogs.Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product.Virus-specific RNA synthesis in interferon-treated mouse cells productively infected with Moloney murine leukemia virus.Further studies on the glycosylated gag gene products of Rauscher murine leukemia virus: identification of an N-terminal 45,000-dalton cleavage product.Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA.Common precursor for Rauscher leukemia virus gp69/71, p15(E), and p12(E).Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA.Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein.Characterization of intracellular precursor polyproteins of Moloney murine leukemia virus.Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants.Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.
P2860
Q33634507-4705E615-591B-4BA6-9E1B-FA7E39033C02Q33783618-9130E217-112E-4803-BD73-2571363E4E9AQ33919493-4D14CB7C-FB8F-4DE9-B825-FF70D4C9BFAEQ33923012-52EC3983-F386-4421-94D2-A9E252146634Q35045420-D23FA1DA-9593-4556-820D-B7707BD74DADQ35235249-5D7259B6-C4DB-48E1-B31E-B2B845DD66BDQ35235387-ADB10254-26B6-4EE2-9044-F6EB0A86D20DQ35889311-6ED6F433-0F11-45B5-9489-7787EAC3B7B6Q36491679-6A5FCA58-BCF9-4209-A66F-1CC730669396Q36496937-774C4A4C-1CC3-4222-B3FC-957C0B9C922EQ36503196-CD06B70F-A94E-4A20-9B86-E0AF5F0F54A2Q36503534-A1AFC283-F6DC-41F1-8FB5-3B3EFE9BD94FQ36515869-05D6A720-2BB4-47DC-B114-E0CB50FA060BQ36515922-C7CF8BBE-FBFC-49F2-8FFA-223D064D9EBEQ36523364-DB58CC02-ABA2-4F4B-B395-946F2A6B1747Q36931841-1FE3994A-D3AB-4006-81FD-673F675116AEQ36935270-DEF921BF-ED95-49FD-94E8-A54724CEE189Q37506904-AF9CB520-6D45-45AD-ADCD-F5E4C0D4D43FQ37507683-91EEEADC-D5F9-4FAB-9349-FBC2A6440032Q37584809-8673184E-477B-4B46-954F-B04FA892DAA7Q37601742-52261BF5-6666-4573-8C97-13F7B70D3CA6Q38304776-657ED6FC-1B9F-4662-A0AD-23A89970DC02Q40143497-79F4A3A2-BD94-46B2-B721-78BFCC6717C9
P2860
Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Selective decrease in the rate ...... ected cells with actinomycin D
@ast
Selective decrease in the rate ...... ected cells with actinomycin D
@en
type
label
Selective decrease in the rate ...... ected cells with actinomycin D
@ast
Selective decrease in the rate ...... ected cells with actinomycin D
@en
prefLabel
Selective decrease in the rate ...... ected cells with actinomycin D
@ast
Selective decrease in the rate ...... ected cells with actinomycin D
@en
P2093
P2860
P1433
P1476
Selective decrease in the rate ...... ected cells with actinomycin D
@en
P2093
Arlinghaus RB
Jamjoom GA
P2860
P304
P407
P577
1976-09-01T00:00:00Z